Gain of multiple copies of the CBFB gene: a new genetic aberration in a case of granulocytic sarcoma.

Cancer Genet Cytogenet

Laboratory of Cytogenetics and Molecular Biology and Laboratory of Hematological Cytology (URNHE-IMAS/IMIM and URTTS-IMAS/IMIM), Pathology Service, Hospital del Mar, Passeig Marítim, 25-29, 08003 Barcelona, Spain.

Published: November 2007

Granulocytic sarcomas (GS) are tumor masses of immature myeloid cells presenting at an extramedullary site, mainly the skin, bone, and lymph node. They are often associated with acute myeloid leukemia (AML) with monoblastic or myelomonocytic differentiation, including either AML M2 with t(8;21)(q22;q22) or AML M4Eo with inv(16)(p13q22). We present a case diagnosed with GS associated with AML M4 that presented a normal karyotype with conventional cytogenetic analysis. Although the myeloblasts did not show the inv(16)(p13q22) (CBFB/MYH11), a gain of multiple copies of the CBFB gene was detected with fluorescence in situ hybridization analysis. To our knowledge, no cases with this rare genetic anomaly have been previously described.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2007.07.018DOI Listing

Publication Analysis

Top Keywords

gain multiple
8
multiple copies
8
copies cbfb
8
cbfb gene
8
gene genetic
4
genetic aberration
4
aberration case
4
case granulocytic
4
granulocytic sarcoma
4
sarcoma granulocytic
4

Similar Publications

Background: Disturbances in DNA damage repair may lead to cancer. SIRT1, an NAD+-dependent deacetylase, plays a crucial role in maintaining cellular homeostasis through the regulation of processes such as histone posttranslational modifications, DNA repair, and cellular metabolism. However, a comprehensive exploration of SIRT1's involvement in pan-cancer remains lacking.

View Article and Find Full Text PDF

Despite the increasing demand for sustainable development of pharmaceutical companies due to the rigorous pressure of environmental regulation, public health crisis and economic competition, there has been little research on relevant evaluation models. The COVID-19 experience has also prompted investors in pharmaceutical companies to re-examine the impact of environment and ethics on business development. Therefore, pharmaceutical companies need to focus on their performance, especially on the shift from a single financial performance to an integrated performance.

View Article and Find Full Text PDF

Aim: The lungs represent the second most common site of colorectal cancer metastases. Although surgery is commonly considered the best treatment, many other invasive and noninvasive procedures and treatments have been adopted to improve patient survival and there is no clear evidence in the literature of which is the more effective. The aim of this work was to identify which treatment confers the best gain in overall survival for patients with pulmonary metastases from colorectal cancer.

View Article and Find Full Text PDF

Objective: The objective of this study was to ascertain the knowledge level of animal breeders and butchers regarding cystic echinococcosis (CE) in the Ardahan province and its districts situated in the Eastern Anatolia Region of Türkiye. Additionally, the study aimed to identify the potential risk factors that may contribute to the occurrence of the disease.

Methods: The research was conducted between November 2021 and May 2022.

View Article and Find Full Text PDF

Background: Hypertension (HTN) is well-known as a major risk factor for various noncommunicable diseases. Evidence indicates a link between socioeconomic status and the likelihood of developing HTN. A thorough comprehension of the inequalities in HTN is crucial for implementing evidence-based interventions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!